Companies: 10,838     total market cap: NZ$251.962 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚ฌEUR๐Ÿ‡ช๐Ÿ‡บโ‚นINR๐Ÿ‡ฎ๐Ÿ‡ณยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
BrainStorm Cell Therapeutics
BCLI
#10528
Rank
NZ$13.4 M
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
NZ$1.21
Share price
6.03%
Change (1 day)
-31.71%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories

Earnings for BrainStorm Cell Therapeutics (BCLI)

Earnings in 2025 (TTM): -NZ$18.73 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$19.59 Million, an increase over its 2023 earnings that were of -NZ$28.97 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BrainStorm Cell Therapeutics from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$18.73 Million-4.39%
2024 -NZ$19.59 Million-32.39%
2023 -NZ$28.97 Million-29.18%
2022 -NZ$40.9 Million-0.74%
2021 -NZ$41.21 Million-23.12%
2020 -NZ$53.6 Million36.8%
2019 -NZ$39.18 Million66.71%
2018 -NZ$23.5 Million181.66%
2017 -NZ$8.35 Million-0.6%
2016 -NZ$8.4 Million-41.31%
2015 -NZ$14.3 Million-8.22%
2014 -NZ$15.59 Million89.74%
2013 -NZ$8.22 Million42.27%
2012 -NZ$5.78 Million-12.45%
2011 -NZ$6.6 Million63.04%
2010 -NZ$4.05 Million35.52%
2009 -NZ$2.99 Million-48.99%
2008 -NZ$5.85 Million-44.39%
2007 -NZ$10.52 Million
2005 -NZ$5.45 Million-91.44%
2004 -NZ$63.65 Million94007.62%
2003 -NZ$0.07 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Biogen
BIIB
NZ$2.73 B-15,064.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$16.50 B-90,428.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-NZ$1.34 Billion 7,189.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-NZ$1.4 Billion 7,549.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
NZ$34.81 M-290.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
-NZ$0.44 Billion 2,255.61%๐Ÿ‡บ๐Ÿ‡ธ USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com